HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margins of Excision

The edges of tissue removed in a surgery for assessment of the effectiveness of a surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. When the margin is negative or not involved by tumor (e.g., CANCER) it suggests all of the tumor has been removed by the surgery.
Also Known As:
Negative Surgical Margins; Positive Surgical Margins; Resection Margin; Surgical Margins; Tumor-Free Margins; Excision Margin; Excision Margins; Margin, Resection; Margin, Surgical; Margin, Tumor-Free; Margins, Resection; Margins, Surgical; Margins, Tumor-Free; Negative Surgical Margin; Positive Surgical Margin; Resection Margins; Surgical Margin; Surgical Margin, Negative; Surgical Margin, Positive; Surgical Margins, Negative; Surgical Margins, Positive; Tumor Free Margins; Tumor-Free Margin
Networked: 8365 relevant articles (355 outcomes, 658 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Carcinoma (Carcinomatosis)
4. Prostatic Neoplasms (Prostate Cancer)
5. Rectal Neoplasms (Rectal Cancer)

Experts

1. Graefen, Markus: 46 articles (01/2022 - 04/2003)
2. Karakiewicz, Pierre I: 38 articles (10/2020 - 12/2005)
3. Montorsi, Francesco: 34 articles (01/2022 - 07/2004)
4. Scardino, Peter T: 31 articles (01/2022 - 02/2002)
5. Huland, Hartwig: 30 articles (01/2022 - 04/2003)
6. Shariat, Shahrokh F: 29 articles (12/2021 - 03/2004)
7. Eastham, James A: 28 articles (01/2022 - 12/2003)
8. Briganti, Alberto: 27 articles (01/2021 - 12/2006)
9. Freedland, Stephen J: 26 articles (10/2020 - 02/2002)
10. Tilki, Derya: 23 articles (01/2022 - 08/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Margins of Excision:
1. Hormones (Hormone)IBA
2. Prostate-Specific Antigen (Semenogelase)IBA
3. AndrogensIBA
4. ParaffinIBA
5. Biomarkers (Surrogate Marker)IBA
6. Carcinoembryonic AntigenIBA
08/27/2023 - "A hybrid predicting model was created through multivariable logistic regression analysis, integrating the radiomics score with significant clinical risk factors (baseline Carcinoembryonic Antigen (CEA), clinical circumferential resection margin status, and the short axis diameter of LPLN). "
01/01/2023 - "Radiomic Nomo charts were developed using Rad scores obtained from the integrated image omics model, circumferential resection margin(CRM), DoTD, and carcinoembryonic antigen(CEA). "
01/01/2022 - "Risk factors for decreased overall survival included age >75 (hazard ratio 3.3, P < .001), male sex (hazard ratio 1.2, P < .001), White/Black race (hazard ratio 1.4, P = .020), preoperative carcinoembryonic antigen >3.5 ng/mL (hazard ratio 1.6, P < .001), T4a T-stage (hazard ratio 2.0, P < .001), T4b T-stage (hazard ratio 2.4, P < .001), lymphovascular invasion (hazard ratio 1.2, P = .003), perineural invasion (hazard ratio 1.3, P = .003), and non-R0 proximal/distal resection margins (hazard ratio 1.7, P < .001). "
11/01/2020 - "Risk factors including elevated preoperative carcinoembryonic antigen (CEA), higher ypTNM stage, positive circumferential resection margin (CRM), and perineural invasion were significantly associated with ER. "
10/02/2020 - "Additionally, univariate analysis identified the MRI circumferential resection margin (mrCRM) and pre-treatment carcinoembryonic antigen (CEA) as significant predictor of RFS (HR 2.082, 95% CI 1.106-3.919; p = 0.023 and HR 1.005, 95% CI 1.002-1.008; p < 0.001). "
7. Imatinib Mesylate (Gleevec)FDA Link
8. TitaniumIBA
9. Formaldehyde (Formol)FDA Link
10. Capsules (Microcapsules)IBA

Therapies and Procedures

1. Radiotherapy
2. Therapeutics
3. Drug Therapy (Chemotherapy)
4. Prostatectomy (Retropubic Prostatectomy)
5. Adjuvant Chemotherapy